| 1 | + | *EH1254.1* |
---|
| 2 | + | February 11, 2022 |
---|
| 3 | + | ENGROSSED |
---|
| 4 | + | HOUSE BILL No. 1254 |
---|
| 5 | + | _____ |
---|
| 6 | + | DIGEST OF HB 1254 (Updated February 9, 2022 11:37 am - DI 140) |
---|
| 7 | + | Citations Affected: IC 16-41. |
---|
| 8 | + | Synopsis: Newborn screening requirements. Provides that beginning |
---|
| 9 | + | July 1, 2022, only a disorder recommended by a perinatal genetics and |
---|
| 10 | + | genomics advisory committee (committee) with expertise in newborn |
---|
| 11 | + | screening, and through protocols prescribed by the state department, |
---|
| 12 | + | may be added to the list of disorders requiring the examination of |
---|
| 13 | + | infants. Provides that beginning July 1, 2022, a committee with |
---|
| 14 | + | expertise in newborn screening, and through protocols established by |
---|
| 15 | + | the state department, may recommend the addition of a disorder to, or |
---|
| 16 | + | deletion of a disorder from, the required examination. Provides that the |
---|
| 17 | + | state department shall adopt rules to add disorders to, or delete |
---|
| 18 | + | disorders from, the required examination. Provides that the state |
---|
| 19 | + | department shall include any disorder added to or deleted from the |
---|
| 20 | + | required examination on a list on the state department's Internet web |
---|
| 21 | + | site. Provides that the committee shall affirm the addition of, or |
---|
| 22 | + | deletion of, any disorder to the examination requirement on an annual |
---|
| 23 | + | basis. |
---|
| 24 | + | Effective: July 1, 2022. |
---|
| 25 | + | Barrett, Rowray, Porter |
---|
| 26 | + | (SENATE SPONSORS — CHARBONNEAU, BROWN L) |
---|
| 27 | + | January 6, 2022, read first time and referred to Committee on Public Health. |
---|
| 28 | + | January 13, 2022, reported — Do Pass. Referred to Committee on Ways and Means |
---|
| 29 | + | pursuant to Rule 127. |
---|
| 30 | + | January 20, 2022, amended, reported — Do Pass. |
---|
| 31 | + | January 24, 2022, read second time, ordered engrossed. Engrossed. |
---|
| 32 | + | January 25, 2022, read third time, passed. Yeas 90, nays 0. |
---|
| 33 | + | SENATE ACTION |
---|
| 34 | + | February 2, 2022, read first time and referred to Committee on Health and Provider |
---|
| 35 | + | Services. |
---|
| 36 | + | February 10, 2022, reported favorably — Do Pass; reassigned to Committee on |
---|
| 37 | + | Appropriations. |
---|
| 38 | + | EH 1254—LS 7009/DI 104 February 11, 2022 |
---|
14 | | - | SECTION 1. IC 16-41-17-2, AS AMENDED BY P.L.19-2020, |
---|
15 | | - | SECTION 1, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE |
---|
16 | | - | JULY 1, 2022]: Sec. 2. (a) Subject to subsection (d), every infant shall |
---|
17 | | - | be given examinations at the earliest feasible time for the detection of |
---|
18 | | - | the following disorders: |
---|
19 | | - | (1) Phenylketonuria. |
---|
20 | | - | (2) Hypothyroidism. |
---|
21 | | - | (3) Hemoglobinopathies, including sickle cell anemia. |
---|
22 | | - | (4) Galactosemia. |
---|
23 | | - | (5) Maple Syrup urine disease. |
---|
24 | | - | (6) Homocystinuria. |
---|
25 | | - | (7) Inborn errors of metabolism that result in an intellectual |
---|
26 | | - | disability and that are designated by the state department. |
---|
27 | | - | (8) Congenital adrenal hyperplasia. |
---|
28 | | - | (9) Biotinidase deficiency. |
---|
29 | | - | (10) Disorders detected by tandem mass spectrometry or other |
---|
30 | | - | technologies with the same or greater detection capabilities as |
---|
31 | | - | tandem mass spectrometry, if the state department determines that |
---|
32 | | - | the technology is available for use by a designated laboratory |
---|
33 | | - | under section 7 of this chapter. |
---|
34 | | - | (11) Spinal muscular atrophy. |
---|
35 | | - | (12) Severe combined immunodeficiency. |
---|
36 | | - | HEA 1254 2 |
---|
37 | | - | (13) Beginning July 1, 2020, Krabbe disease. |
---|
38 | | - | (14) Beginning July 1, 2020, Pompe disease. |
---|
39 | | - | (15) Beginning July 1, 2020, Hurler syndrome (MPS1). |
---|
40 | | - | (16) Adrenoleukodystrophy (ALD). |
---|
41 | | - | (17) Beginning July 1, 2022, and in addition to the disorders |
---|
42 | | - | listed in subdivisions (1) through (16), only a disorder |
---|
43 | | - | recommended by a perinatal genetics and genomics advisory |
---|
44 | | - | committee with expertise in newborn screening and through |
---|
45 | | - | protocols prescribed by the state department. |
---|
46 | | - | Beginning July 1, 2022, a perinatal genetics and genomics advisory |
---|
47 | | - | committee with expertise in newborn screening, and through |
---|
48 | | - | protocols established by the state department, may recommend the |
---|
49 | | - | addition of a disorder to, or deletion of a disorder from, the |
---|
50 | | - | required examination under this subsection. The state department |
---|
51 | | - | shall adopt rules under IC 4-22-2 to add disorders to, or delete |
---|
52 | | - | disorders from, the required examination under this subsection. |
---|
53 | | - | The state department shall include any disorder added to or |
---|
54 | | - | deleted from the required examination on a list on the state |
---|
55 | | - | department's Internet web site. The perinatal genetics and |
---|
56 | | - | genomics advisory committee shall affirm the addition of, or |
---|
57 | | - | deletion of, any disorder to the examination requirement on an |
---|
58 | | - | annual basis. |
---|
59 | | - | (b) Subject to subsection (d), every infant shall be given a |
---|
60 | | - | physiologic hearing screening examination at the earliest feasible time |
---|
61 | | - | for the detection of hearing impairments. |
---|
62 | | - | (c) Subject to subsection (d), every infant shall be given a pulse |
---|
63 | | - | oximetry screening examination in accordance with rules adopted by |
---|
64 | | - | the state department for the detection of low oxygen levels. Section |
---|
65 | | - | 10(a)(2) of this chapter does not apply to this subsection. |
---|
66 | | - | (d) If a parent of an infant objects in writing, for reasons pertaining |
---|
67 | | - | to religious beliefs only, the infant is exempt from the examinations |
---|
68 | | - | required by this chapter. |
---|
69 | | - | HEA 1254 Speaker of the House of Representatives |
---|
70 | | - | President of the Senate |
---|
71 | | - | President Pro Tempore |
---|
72 | | - | Governor of the State of Indiana |
---|
73 | | - | Date: Time: |
---|
74 | | - | HEA 1254 |
---|
| 54 | + | 1 SECTION 1. IC 16-41-17-2, AS AMENDED BY P.L.19-2020, |
---|
| 55 | + | 2 SECTION 1, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE |
---|
| 56 | + | 3 JULY 1, 2022]: Sec. 2. (a) Subject to subsection (d), every infant shall |
---|
| 57 | + | 4 be given examinations at the earliest feasible time for the detection of |
---|
| 58 | + | 5 the following disorders: |
---|
| 59 | + | 6 (1) Phenylketonuria. |
---|
| 60 | + | 7 (2) Hypothyroidism. |
---|
| 61 | + | 8 (3) Hemoglobinopathies, including sickle cell anemia. |
---|
| 62 | + | 9 (4) Galactosemia. |
---|
| 63 | + | 10 (5) Maple Syrup urine disease. |
---|
| 64 | + | 11 (6) Homocystinuria. |
---|
| 65 | + | 12 (7) Inborn errors of metabolism that result in an intellectual |
---|
| 66 | + | 13 disability and that are designated by the state department. |
---|
| 67 | + | 14 (8) Congenital adrenal hyperplasia. |
---|
| 68 | + | 15 (9) Biotinidase deficiency. |
---|
| 69 | + | 16 (10) Disorders detected by tandem mass spectrometry or other |
---|
| 70 | + | 17 technologies with the same or greater detection capabilities as |
---|
| 71 | + | EH 1254—LS 7009/DI 104 2 |
---|
| 72 | + | 1 tandem mass spectrometry, if the state department determines that |
---|
| 73 | + | 2 the technology is available for use by a designated laboratory |
---|
| 74 | + | 3 under section 7 of this chapter. |
---|
| 75 | + | 4 (11) Spinal muscular atrophy. |
---|
| 76 | + | 5 (12) Severe combined immunodeficiency. |
---|
| 77 | + | 6 (13) Beginning July 1, 2020, Krabbe disease. |
---|
| 78 | + | 7 (14) Beginning July 1, 2020, Pompe disease. |
---|
| 79 | + | 8 (15) Beginning July 1, 2020, Hurler syndrome (MPS1). |
---|
| 80 | + | 9 (16) Adrenoleukodystrophy (ALD). |
---|
| 81 | + | 10 (17) Beginning July 1, 2022, and in addition to the disorders |
---|
| 82 | + | 11 listed in subdivisions (1) through (16), only a disorder |
---|
| 83 | + | 12 recommended by a perinatal genetics and genomics advisory |
---|
| 84 | + | 13 committee with expertise in newborn screening and through |
---|
| 85 | + | 14 protocols prescribed by the state department. |
---|
| 86 | + | 15 Beginning July 1, 2022, a perinatal genetics and genomics advisory |
---|
| 87 | + | 16 committee with expertise in newborn screening, and through |
---|
| 88 | + | 17 protocols established by the state department, may recommend the |
---|
| 89 | + | 18 addition of a disorder to, or deletion of a disorder from, the |
---|
| 90 | + | 19 required examination under this subsection. The state department |
---|
| 91 | + | 20 shall adopt rules under IC 4-22-2 to add disorders to, or delete |
---|
| 92 | + | 21 disorders from, the required examination under this subsection. |
---|
| 93 | + | 22 The state department shall include any disorder added to or |
---|
| 94 | + | 23 deleted from the required examination on a list on the state |
---|
| 95 | + | 24 department's Internet web site. The perinatal genetics and |
---|
| 96 | + | 25 genomics advisory committee shall affirm the addition of, or |
---|
| 97 | + | 26 deletion of, any disorder to the examination requirement on an |
---|
| 98 | + | 27 annual basis. |
---|
| 99 | + | 28 (b) Subject to subsection (d), every infant shall be given a |
---|
| 100 | + | 29 physiologic hearing screening examination at the earliest feasible time |
---|
| 101 | + | 30 for the detection of hearing impairments. |
---|
| 102 | + | 31 (c) Subject to subsection (d), every infant shall be given a pulse |
---|
| 103 | + | 32 oximetry screening examination in accordance with rules adopted by |
---|
| 104 | + | 33 the state department for the detection of low oxygen levels. Section |
---|
| 105 | + | 34 10(a)(2) of this chapter does not apply to this subsection. |
---|
| 106 | + | 35 (d) If a parent of an infant objects in writing, for reasons pertaining |
---|
| 107 | + | 36 to religious beliefs only, the infant is exempt from the examinations |
---|
| 108 | + | 37 required by this chapter. |
---|
| 109 | + | EH 1254—LS 7009/DI 104 3 |
---|
| 110 | + | COMMITTEE REPORT |
---|
| 111 | + | Mr. Speaker: Your Committee on Public Health, to which was |
---|
| 112 | + | referred House Bill 1254, has had the same under consideration and |
---|
| 113 | + | begs leave to report the same back to the House with the |
---|
| 114 | + | recommendation that said bill do pass. |
---|
| 115 | + | (Reference is to HB 1254 as introduced.) |
---|
| 116 | + | BARRETT |
---|
| 117 | + | Committee Vote: Yeas 11, Nays 0 |
---|
| 118 | + | _____ |
---|
| 119 | + | COMMITTEE REPORT |
---|
| 120 | + | Mr. Speaker: Your Committee on Ways and Means, to which was |
---|
| 121 | + | referred House Bill 1254, has had the same under consideration and |
---|
| 122 | + | begs leave to report the same back to the House with the |
---|
| 123 | + | recommendation that said bill be amended as follows: |
---|
| 124 | + | Page 2, line 15, before "The state" insert "Beginning July 1, 2022, |
---|
| 125 | + | a perinatal genetics and genomics advisory committee with |
---|
| 126 | + | expertise in newborn screening, and through protocols established |
---|
| 127 | + | by the state department, may recommend the addition of a |
---|
| 128 | + | disorder to, or deletion of a disorder from, the required |
---|
| 129 | + | examination under this subsection. The state department shall |
---|
| 130 | + | adopt rules under IC 4-22-2 to add disorders to, or delete disorders |
---|
| 131 | + | from, the required examination under this subsection.". |
---|
| 132 | + | Page 2, line 15, after "added to" insert "or deleted from". |
---|
| 133 | + | Page 2, line 16, delete "by subdivision (17)". |
---|
| 134 | + | Page 2, line 18, after "addition of" insert ", or deletion of,". |
---|
| 135 | + | Page 2, line 19, delete "under subdivision (17)". |
---|
| 136 | + | Page 2, delete lines 31 through 42. |
---|
| 137 | + | Delete page 3. |
---|
| 138 | + | and when so amended that said bill do pass. |
---|
| 139 | + | (Reference is to HB 1254 as printed January 13, 2022.) |
---|
| 140 | + | BROWN T |
---|
| 141 | + | Committee Vote: yeas 22, nays 0. |
---|
| 142 | + | EH 1254—LS 7009/DI 104 4 |
---|
| 143 | + | COMMITTEE REPORT |
---|
| 144 | + | Madam President: The Senate Committee on Health and Provider |
---|
| 145 | + | Services, to which was referred House Bill No. 1254, has had the same |
---|
| 146 | + | under consideration and begs leave to report the same back to the |
---|
| 147 | + | Senate with the recommendation that said bill DO PASS and be |
---|
| 148 | + | reassigned to the Senate Committee on Appropriations. |
---|
| 149 | + | (Reference is to HB 1254 as printed January 20, 2022.) |
---|
| 150 | + | CHARBONNEAU, Chairperson |
---|
| 151 | + | Committee Vote: Yeas 9, Nays 0 |
---|
| 152 | + | EH 1254—LS 7009/DI 104 |
---|